Cetaphil “Bonus Size” Containers
June 2017: This action was voluntarily dismissed, the reasons for which have not been disclosed. The named plaintiff’s claims were dismissed When a complaint is dismissed with prejudice, it cannot…
March 2017: This action was dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed.
September 2016: A false advertising class-action lawsuit was filed against Galderma Laboratories in September 2016 (and transferred to federal court in October 2016) for allegedly misleadingly representing that Cetaphil® skin care products treat or mitigate eczema when, in reality, they do not. (Greenberg et al v. Galderma Laboratories, L.P. and Does 1-100, Case No. 16-cv-6090, N. D. CA.)
Medicare “open enrollment,” which starts Oct. 15, is also open season for scammers.
TINA.org supports FTC’s proposed rule and suggests revisions.
HIP HOP PSA: “We need real prices and transparency in healthcare.”
But the majority of brand partners will still lose money.